Positive clinical trial results for olaparib in advanced prostate cancer 07 Aug 2019 The preliminary results of a major phase III clinical trial show that the genetically targeted drug olaparib improves outcomes for men with advanced prostate cancer whose tumours have DNA repair faults. Find out more Show/Hide
Gene test picks out prostate cancers patients who could benefit from ‘search-and-destroy’ medicine 23 Jul 2019 Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports. Find out more Show/Hide
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019 A pioneering gene-targeted drug already licensed for breast and ovarian cancer can benefit some men with prostate cancer, a major new clinical trial reports. Find out more Show/Hide
Protein found more in advanced prostate cancer could be key to preventing drug resistance 08 Jan 2019
Cancer researchers, family and friends gather to celebrate award of Queen’s Regius Professorship to Professor Johann de Bono 20 Sep 2018
Tiny changes in prostate cancer blood test could spot early warning signs of treatment not working 16 Jul 2018